(Total Views: 106)
Posted On: 04/25/2023 10:15:47 AM
Post# of 85382
$TGTX News Article - TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 75th Annual Meeting https://marketwirenews.com/news-releases/tg-t...22761.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
